NYXH vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, AONC, and APLMW
Should you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), American Oncology Network (AONC), and Apollomics (APLMW). These companies are all part of the "medical" sector.
Nyxoah (NASDAQ:NYXH) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.
Nyxoah presently has a consensus target price of $20.20, indicating a potential upside of 100.00%. Given Nyxoah's higher possible upside, analysts plainly believe Nyxoah is more favorable than 180 Life Sciences.
180 Life Sciences has a net margin of 0.00% compared to Nyxoah's net margin of -843.48%. 180 Life Sciences' return on equity of 0.00% beat Nyxoah's return on equity.
In the previous week, Nyxoah had 17 more articles in the media than 180 Life Sciences. MarketBeat recorded 18 mentions for Nyxoah and 1 mentions for 180 Life Sciences. Nyxoah's average media sentiment score of 0.16 beat 180 Life Sciences' score of 0.00 indicating that Nyxoah is being referred to more favorably in the media.
180 Life Sciences has lower revenue, but higher earnings than Nyxoah.
Nyxoah received 29 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
Summary
Nyxoah beats 180 Life Sciences on 6 of the 9 factors compared between the two stocks.
Get Nyxoah News Delivered to You Automatically
Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
